Drugplain

ZOLADEX 10.8 mg/1

goserelin · IMPLANT · TerSera Therapeutics LLC

No Recall History
Plain English

ZOLADEX is a implant containing goserelin at 10.8 mg/1, taken subcutaneous. Manufactured by TerSera Therapeutics LLC.

Key Facts

Brand Name
ZOLADEX
Generic Name
goserelin
NDC Code (Product)
70720-951
Manufacturer
TerSera Therapeutics LLC
Strength
10.8 mg/1
Dosage Form
IMPLANT
Route
SUBCUTANEOUS
Marketing Status
Application #
NDA020578
Marketing Start
01/26/2018

Recall History

No Recall History

Frequently Asked Questions

What is ZOLADEX used for?

ZOLADEX contains goserelin. It is a implant taken subcutaneous. Consult your doctor for specific uses.

Is ZOLADEX a controlled substance?

ZOLADEX is not classified as a controlled substance by the DEA.

What is the generic name for ZOLADEX?

The generic name for ZOLADEX is goserelin. There are no other listed brand versions of goserelin.

What is the NDC code for ZOLADEX 10.8 mg/1?

The NDC (National Drug Code) for ZOLADEX 10.8 mg/1 is 70720-951, listed by TerSera Therapeutics LLC.

Product NDC

70720-951

Package NDC

70720-951-30

Other ZOLADEX Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)